fda shortage list semaglutide FDA: Novo Nordisk's Ozempic and Wegovy, long in shortage, now available What's New in Obesity Treatment?

Adults During the COVID-19 Pandemic

Saddiq Qazi, Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark

Of these, two studies ( N = 16 and N = 46, respectively) observed a positive association between the use of exenatide, liraglutide or dulaglutide and weight loss as well as HbA1c at 16 weeks 149 and 1 year 150 , while for the smaller one ( N = 7) this association was not significant 148

The new GLP1 is produced by drug maker Eli Lilly, designed to be taken once a day to treat obesity and adults

The lowest verified prices in 2026 are $259 per month through licensed telehealth programs for compounded tirzepatide and $299 per month through LillyDirect for FDA-approved brand-name Zepbound vials

What is the expected annual volume and cost target